Please login to the form below

Not currently logged in
Email:
Password:

market

This page shows the latest market news and features for those working in and with pharma, biotech and healthcare.

Novo Nordisk announces positive phase 3 results for oral weight-loss drug

Novo Nordisk announces positive phase 3 results for oral weight-loss drug

Semaglutide is already available in major markets as a once-weekly injection. ... Semaglutide is already available in major markets for weight management under the brand names Wegovy and Rybelsus as a once-weekly injection.

Latest news

More from news
Approximately 163 fully matching, plus 4,829 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 91 fully matching, plus 745 partially matching documents found.

Latest appointments

More from appointments
Approximately 9 fully matching, plus 433 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 234 fully matching, plus 1,471 partially matching documents found.

Subscribe to our email news alerts

PMHub

Add my company
Jet Off with Maloff Protect

Latest intelligence

Patient Clinical Trial & Communications Plan Review: A Customer Story
...
Working together to achieve better patient pathways
Digital tools can supercharge patient treatment and outcomes but the importance of the patient voice cannot be underestimated...
Design-thinking. Iterating for continuous improvement.
How design can lead improvement within Pharma...